With the pharma industry constantly changing, delivering consistent quality, safety, and efficacy of pharmaceutical products is now more than a regulatory obligation—it's a responsibility. Among the ...

The global Binder Excipients market, valued at US$2.0 Billion in 2024, is set to reach US$2.7 Billion by 2030 with a CAGR of 5.3%. Key drivers includ ...

However, like other aspects of drug development, it is evolving ... through concepts including stakeholder engagement, Quality by Design (QbD), and Critical to Quality (CtQ) factors.

Tube packaging offers convenience, specialized dispensing, lightweight designs and eco-friendly features. Here are the latest ...

therapeutic development, and drug formulation optimization. Techniques such as molecular docking, virtual screening, artificial intelligence (AI)-driven drug design, and machine learning-based ...